OmniaSecure MRI SureScan Lead Model 3930M
Medtronic, Inc. · Decision date Oct 23, 2026
What did the FDA decide?
The FDA record P240036/S007 concerns the OmniaSecure MRI SureScan Lead Model 3930M, listed under permanent defibrillator electrodes in the cardiovascular specialty, with Medtronic, Inc. as applicant. The supplement is a 30-Day Notice, and its reason field is a process change covering manufacturer, sterilizer, packager or supplier. Its stated purpose is to add an additional in-process inspection during the manufacturing of the OmniaSecure leads.
Indexed under PMA P240036, this filing amends manufacturing for the referenced lead rather than constituting a new approval of the whole system. The record does not identify the inspection step, the manufacturing stage it follows, acceptance criteria, or supporting data, and the stated purpose does not by itself establish safety or clinical effectiveness.
The date on the record is 2026-10-23 and the decision entry reads OK30.
FDA approval order statement
to add an additional in-process inspection during the manufacturing of the OmniaSecure leads
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Oct 23, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P240036/S007
- Regulatory pathway
- PMA supplement
- Applicant
- Medtronic, Inc.
- Product code
- NVY
- Decision code
- OK30
- Decision date
- Oct 23, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Permanent defibrillator electrodes.
- Applicant
- Medtronic, Inc.
- Product code
- NVY
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P240036. Subsequent supplements may change the device or its indications.
FDA decision timeline
P240036 · Original PMA
OmniaSecure MRI SureScan Lead Model 3930M
P240036/S007 received
Application receipt date recorded by FDA.
P240036/S007 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P240036. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P240036
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Medtronic, Inc. | PMA approval | Apr 22, 2025 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Medtronic, Inc.
- Headquarters
- Not reported
- Brand website
- medtronic.com
- FDA applicant address
- 8200 Coral Sea St. N.E, Mounds View, MN, 55112
Sources and methodology
- Original FDA record: P240036/S007
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records